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Combinatorial interactions among transcription
factors are critical to directing tissue-specific gene
expression. To build a global atlas of these combina-
tions, we have screened for physical interactions
among the majorityof humanand mouseDNA-binding
transcription factors (TFs). The complete networks
contain 762 human and 877 mouse interactions. Anal-
ysis of the networks reveals that highly connected TFs744 Cell 140, 744–752, March 5, 2010 ª2010 Elsevier Inc.are broadly expressed across tissues, and that
roughly half of the measured interactions are
conserved between mouse and human. The data
highlight the importance of TF combinations for deter-
mining cell fate, and they lead to the identification of
a SMAD3/FLI1 complex expressed during develop-
ment of immunity. The availability of large TF combi-
natorial networks in both human and mouse will
provide many opportunities to study gene regulation,
tissue differentiation, and mammalian evolution.
INTRODUCTION
Tissue specificity is enabled by spatial and temporal patterns of
gene expression which in turn are driven by transcriptional regu-
latory networks (Naef and Huelsken, 2005; Zhang et al., 2004).
Such networks involve assemblies of control proteins, such as
DNA-binding transcription factors (TFs) connected to the sets
of promoters of genes they induce or repress (Tan et al.,
2008b). Typically, TFs do not act independently but form
complexes with other TFs, chromatin modifiers, and cofactor
proteins, which bind together and assemble upon the regulatory
regions of DNA to affect transcription (Fedorova and Zink, 2008).
Mapping the combinatorial interactions among TFs would repre-
sent a significant leap forward in our understanding of how tissue
specificity is determined.
In recent years, a variety of genome-scale technologies have
been introduced which allow mammalian transcriptional regula-
tory networks to be investigated at high resolution and depth.
Many such studies have inferred transcriptional networks
through mRNA expression profiling combined with genome-
wide active promoter mapping and promoter motif analysis
(e.g., Suzuki et al., 2009). These data have been supplemented
with fluorescence-activated cell sorting (FACS) (Shachaf et al.,
2008) or reverse transcriptase quantitative polymerase chain
reaction (qRT-PCR) (Roach et al., 2007; Wen et al., 1998).
Another technology that has revolutionized the study of tran-
scriptional networks is chromatin immunoprecipitation (ChIP),
which when coupled with microarrays or high-throughput
sequencing (Johnson et al., 2007), enables genome-wide
measurements of TF binding locations in vivo. A complementary
approach is the protein binding microarray (PBM) (Berger et al.,
2008), which rapidly characterizes the complete DNA sequence
repertoire bound by a TF in vitro. ChIP and PBMs have been
applied to map transcriptional networks in a variety of human
cell types, including stem cells (Cole et al., 2008; Lee et al.,
2006) and lymphocytes (Marson et al., 2007; Schreiber et al.,
2006), and to characterize the binding motifs of many mamma-
lian TF families (Berger et al., 2008).
Although these studies have led to the construction of very
large models of transcriptional networks, they are based on
experiments that largely treat each TF in isolation. For instance,
ChIP-chip measures binding locations for one TF at a time,
although separate profiles for several TFs can be later combined
into networks (Mathur et al., 2008). However, it is well known that
the transcriptional output of a gene is due to the joint activity of
many TFs whose binding and activation are highly interdepen-
dent. This cooperation is often mediated by direct physical
contact between two or more TFs, forming homodimers, hetero-
dimers, or larger transcriptional complexes. In fact, it has been
estimated that approximately 75% of all metazoan TFs heterodi-
merize with other factors (Walhout, 2006). Newman and Keating
usedproteinarrays to reveal anetworkof severalhundreddomain
interactions among the bZIP TF family alone (Grigoryan et al.,
2009).Other studieshavesuccessfully assembled largenetworks
of protein interactions using technologies such as coimmunopre-
cipitation and two-hybrid screening (Park et al., 2005; Yu et al.,
2008), but to date these have not been systematically applied to
map networks of transcription factors. Thus, a clear and imme-diate task is to map which combinations of TFs act together
and how these combinations lead to modes of regulation that
are not evident when each factor is considered separately.
Toward this goal, we have pursued an integrative approach to
systematically map combinatorial interactions among mammalian
TFs.Our approach draws from two systems-wide data sets gener-
ated inbothhumanandmouse:physicalprotein-protein interaction
among TFs measured using the mammalian two-hybrid (M2H)
system and quantitative TF expression levels measured across
tissues by qRT-PCR. Analysis of these data identifies a database
of TF complexes and networks that can be used to elucidate the
regulatory programs behind developmental processes and
disease. Chief among these results is a network of homeobox
TFs, which we show can predict tissue type in mammals.
RESULTS
Mammalian Transcription Factor Protein-Protein
Interaction Networks
We compiled a list of 1988 human and 1727mouse DNA-binding
transcription factors using information from public gene data-
bases (Table S1). Of these, 1222 and 1112 cDNA clones were
captured, in human and mouse, respectively, that could be
verified to express full-length protein (Table S1). All pair-wise
combinations of TF cDNAs were systematically screened for
protein-protein interaction using the M2H system (Suzuki et al.,
2001). Bait and prey constructs were cotransfected in CHO-K1
cells, and the interactionof theexpressedproteinswasmonitored
by luciferase reporter activity. This process identified 762 and
877 high-stringency TF-TF interactions in human and mouse,
respectively (Tables S2 and S3). The use of M2H meant that the
human and mouse TF interactions were measured in near-phys-
iological conditions including mammalian posttranslational and
other modifications. The web-accessible atlas of all pairwise TF
interactions mapped by M2H is available at http://fantom.gsc.
riken.jp/4/tf-ppi. This resource is searchable by gene ID or func-
tion and provides network visualizations as well as raw lists of
interactions.
To estimate the sensitivity of the screening approach (the
percentage of all true TF-TF interactions that are identifiable by
M2H), we assembled a gold-standard set of high-confidence
TF-TF dimers reported in previous literature. To obtain this gold
standard, a setof289mouseTF-TF interactionsweredownloaded
frompublicdatabasesand further curated toselect 91 interactions
supported by two or more independent lines of evidence or
primary experimental reports (Supplemental Information and
Table S3). We found that M2H recovered protein-protein interac-
tions for 23 of these heterodimers, yielding a sensitivity of 25%.
Apart from sensitivity, we were also interested in precision (the
percentageof reported interactions that are true, equal to 1 false
discovery rate). Precision is more difficult to estimate than sensi-
tivity, because it requires a gold standard that contains not only
known interactions but also a large number of protein pairs that
are known to be noninteracting. Since such data are not available,
we sought to confirm the M2H positives using in vitro pull-down
assays as a second technology. Of 34 randomly chosen mouse
M2H positives, 18 (53%) were detected by in vitro pull-down
(Table S4). This second assay is not a gold standard, such thatCell 140, 744–752, March 5, 2010 ª2010 Elsevier Inc. 745
Figure 1. TF Expression versus Connectivity
(A) Distribution of tissue specificity for all TFs. The green curves fit the bi-modal
distribution as a mixture of two Gaussians.
(B) Scatterplot of tissue specificity (y axis) versus number of neighbors (x axis).
Red points are defined as specifier hubs and blue points as facilitator hubs
(Table S1).
(C) TFs are binned into four groups of approximately equal size based on their
number of interactions (x axis). The tissue specificity distribution of each bin is
represented by stacks of colored segments. Segment height represents the
fraction of TFs in an expression group (left y axis), and segment color repre-
sents the number of tissues in which TFs in that group are expressed. The
black line displays the median TSPS of each group (right y axis). The results
shown are for human M2H interactions supplemented with TF-TF interactions
downloaded from literature (Table S2); similar results are obtained for mouse
746 Cell 140, 744–752, March 5, 2010 ª2010 Elsevier Inc.failure to confirm an M2H positive by in vitro pull-down does not
negate the correspondingprotein-protein interaction,whichmight
be transient or unstable under conditions of the pull-down.
However, this analysis does show that theM2H network recovers
approximately one quarter of known TF heterodimers and that the
majority of M2H interactions can be replicated by a second tech-
nology. These figures are consistent with high quality interaction
networks published elsewhere recently (Yu et al., 2008).
We now describe four case studies that use the atlas to
address questions of how transcriptional control contributes to
tissue specificity in mammals. These case studies cover: (1) inte-
gration of the atlas with quantitative TF abundance levels across
human and mouse tissues, revealing a prominent relationship
between TF connectivity and expression; (2) identification of
a subnetwork of homeobox factors that is highly discriminative
and predictive of tissue type; (3) a proteome-wide map of
conserved transcriptional complexes in mammals, many of
which have tissue-specific expression patterns that are also
highly conserved; and (4) examples of how the atlas can be
used to recognize and further explore TF heterodimers in control
of tissue differentiation.Integration of TF Interaction and Expression Reveals
Insights into Network Structure
In order to physically interact, TFs must be coexpressed in the
same tissue or cell type. To investigate the tissue specificity of
TF interactions, we obtained quantitative mRNA profiles of all
TFs using qRT-PCR across a panel of 34 human and 20 mouse
tissues (Table S5). For each TF, we computed a tissue-specificity
score (TSPS), which uses relative entropy to quantify the extent
to which the observed TF expression pattern departs from the
null distribution of uniform expression across all tissues (Exper-
imental Procedures, Table S1, and Table S5). Examination of
tissue specificity over all TFs suggested a mixture of two distinct
TF populations, with one population of TFs having widespread
tissue expression (TSPS < 1) and a second smaller population
at higher tissue specificity (TSPS R 1, Figures 1A and 1B). We
called the TFs with widespread expression ‘‘facilitators,’’ based
on the hypothesis that they facilitate transcriptional programs
across many different tissues, and we called those with high-
specificity tissue ‘‘specifiers.’’ For example, the TFs JUN and
FOS, which form the AP-1 heterodimer, were classified as strong
facilitators owing to low TSPS (average around 0.6; Table S5).
This score is consistent with the classical view of AP-1 as a broad
activator of expression in major cellular processes including
differentiation, proliferation, and apoptosis (Ameyar et al.,
2003). In contrast, many TFs with known roles in tissue differen-
tiation were classified as ‘‘specifiers,’’ such as MYOD1, which
regulates muscle development and members of the Paired box
(Pax) TF family involved in tissue morphogenesis. The observed
bimodal distribution of TF expression is in agreement with recent
findings from a meta-analysis of publicly-available expression
profiles in humans (Vaquerizas et al., 2009).interactions or for M2H interactions only (Table S3; see also Table S4 for con-
firmation of the M2H positives using in vitro pull down assays as a second
technology).
Figure 2. A Homeobox Network Associated
with Tissue Differentiation
(A) Performance of tissue separation with (green
solid curve) or without (black solid curve) in-
formation about TF protein-protein interactions
(Table S2). The Bezdek cluster validity index (CVI,
y axis) is a measure of separation between the
four tissue classes. CVI is plotted for increasing
kernel standard deviation (x axis), the only tuning
parameter of the ncKPCA algorithm used for tissue
separation. Performance was also evaluated for TF
pairs predicted to cooperate based on co-occur-
rence of TF binding sites (yellow curve) (Yu et al.,
2006) as well as for random features (dashed
curves).
(B) Tissue dimensionality reduction by ncKPCA
into the first two Principle Components (PCs),
considering features derived from the six most
informative TF-TF interactions. Points represent
tissues derived from ectoderm (green), mesoderm
(yellow), or endoderm (red), or a monocyte cell line
(blue). Gray circles denote four clusters obtained
by affinity propagation in the (PC1, PC2) space,
with each point connected to its cluster exemplar.
This figure is related to Figure S1.
(C) Informative subnetwork containing six interac-
tions (green) used to generate features for tissue
separation. Also shown are the immediate network
neighbors of the interacting TFs.
(D) CVI for the separation of stem cells (Table S6)
using Sammon Mapping. Four feature sets are
shown: the original expression values from Muller
et al., the expression of the TFs only, the entire
set of TF protein-protein interactions, or the fea-
tures corresponding to the six interactions in panel
C (5* indicates that the interaction HOXA9-MEIS1
was not considered because HOXA9 expression
was not measured in the stem cell investigation
of Muller et al.).
(E) Stem cell dimensionality reduction obtained by
Sammon Mapping using the panel C interaction
set. Points represent stem cell lines derived from
ectoderm (green), mesoderm (yellow), or endo-
derm (red).
(F) Good performance of tissue separation
observed with two different algorithms. ncKPCA
(green curve) and Sammon Mapping (blue curve). CVI (y axis) is plotted against the number of PC2-ranked interactions used to separate tissues (x axis). In
both cases, the maximum performance is observed using the first six PC2-ranked interactions to separate tissues.Examining the relationship between expression and interac-
tion, we observed a strongly negative Pearson correlation of
0.79 between a TF’s number of protein interactions and its
TSPS. That is, we found that TFs with few interactions tend to
be expressed in a tissue-specific pattern while TFs with many
interactions—so called network ‘‘hubs’’ (Jin et al., 2007;
Yu et al., 2006)— tend to be expressed across many tissues
(Figure 1C). The observed correlation was highly significant, as
assessed by 10,000 random trials in which the assignment of
expression values to TFs was permuted (r = 0.00 ± 0.03). Such
widespread expression of TF hubs bears some similarity to
previous studies of TF-DNA (transcriptional) interactions, in
which the number of promoters bound by a TF was found to
correlate with the number of growth conditions in which it is ex-
pressed (Luscombe et al., 2004; Zhou et al., 2008).A Homeobox Network Associated with Specification
of Tissue Type
Combinatorial interaction among transcription factors is critical
for differentiation of tissues (Davidson et al., 2002). To identify
TF interaction networks involved in tissue development, we clus-
tered the TF expression profiles across the 34 human tissues
(see above) using two approaches: a basic tissue separation
approach using expression levels only, and a ‘‘network-trans-
formed’’ approach in which we exploited as features the differ-
ences in expression level across TF-TF interactions, as sug-
gested by a recent study (Taylor et al., 2009). We found that
network transformation resulted in an increased separation of
tissues into four well-formed clusters (a 38% increase, Figures
2A and 2B and Figure S1). These corresponded to well-defined
tissue classes according to embryonic origin: ectodermCell 140, 744–752, March 5, 2010 ª2010 Elsevier Inc. 747
(including central nervous system or CNS), mesoderm, endo-
derm, and cell lines. Strikingly, only six TF interactions were suffi-
cient to classify tissue type with a high accuracy of 82% (Figures
2B and 2C). Moreover, we found that these interactions fell into
the same small network neighborhood defined by a subnetwork
of 15 proteins (Figure 2C). This subnetwork was highly enriched
for homeobox factors (7/15 proteins) many of which have, at
least individually, known roles in tissue-type specification during
development (Duverger and Morasso, 2008). Although we ex-
pected that many of these TFs would be tissue specifiers, we
found that 10 of the 15 were in fact facilitators expressed broadly
across most tissue types. These results support the notion that it
is the interactions among transcription factors more than their
expression levels alone that help to determine tissue identity.
Given the ability of the homeobox-related subnetwork to
separate tissues based on their embryological origin, we sought
to test whether this subnetwork was also able to discriminate
the embryological origin of different types of stem cells. Under-
standing the transcriptional events that commit stem cells to
different tissue lineages is one of the major goals of stem cell
research (Jaenisch, 2009). For this purpose, we downloaded
the publicly-available gene expression profiles of 219 stem
cell lines derived from a variety of different tissue types (Muller
et al., 2008) (Table S6 lists the tissue origin of each cell line).
As shown in Figures 2D and 2E, the homeobox-related subnet-
work was indeed able to separate these stem cell expression
profiles by ectoderm, mesoderm, and endoderm origin. This
separation was 33% better than that achieved using other
methods (Figure 2D). This analysis suggests that the good
performance of the homeobox-related subnetwork (Fig-
ure 2C) is not the result of overfitting to a specific set of tis-
sue expression profiles. Moreover, it provides further evidence
that the combinatorial interactions revealed in this subnetwork
play an important role in cell commitment to different tissue
lineages.
Conservation of TF Complexes across Mammalian
Evolution
A strong line of evidence that a particular TF interaction is func-
tional is observation of cross-species conservation of that inter-
action. For each human TF, we used the InParanoid algorithm
(O’Brien et al., 2005) to identify its set of amino acid sequence or-
thologs in mouse. We then identified pairs of TFs for which the
orthologs were observed to interact in both species. In total,
80 conserved interactions were identified between the M2H
data of human and mouse—this number rose to 305 conserved
interactions when supplementingM2H data with literature (Table
S2 and Table S3). Considering this number together with the
M2H sensitivity and precision estimates above, we computed
the fraction of conserved TF-TF interactions between human
and mouse to be in the range of 34%–64% (depending on the
value one uses for the precision of M2H screening, see Supple-
mental Information).
We next used NetworkBLAST (Kalaev et al., 2008) to examine
how these conserved interactions clustered within the network,
i.e., whether they fell within common subnetworks suggestive
of conserved transcriptional complexes. In total, 68 conserved
complexes were identified which contained approximately six748 Cell 140, 744–752, March 5, 2010 ª2010 Elsevier Inc.TFs on average. Examples of conserved complexes are shown
in Figures 3A–3F; the complete set is included as part of the atlas
at http://fantom.gsc.riken.jp/4/tf-ppi. Eighty percent of the
conserved complexes were enriched for gene ontology biolog-
ical process annotations. These conserved TF complexes
provide a first-draft map of the combinatorial regulatory circuits
common to mammals.
The conserved complexes also suggest combinations of het-
erodimers in specific biological contexts for future investigation.
Figure 3C shows a conserved complex of six TFs in which five
are broadly expressed across all tissues in both species, and
one TF (LHX2) is restricted to frontal cortex also in both species
(Table S5). Figures 3D–3F show three conserved TF complexes
consisting of proteins coexpressed in cerebellum. Messenger
RNA in situ hybridization analysis of mouse cerebellum, obtained
from the Allen Brain Atlas (Lein et al., 2007), confirms that the in-
teracting TFs are indeed expressed in cerebellum and that this
localization is cerebellum-specific at single-cell resolution.
FLI1 and SMAD3 Form a Heterodimeric Complex
Associated with Monocyte Development
The vast majority of TF-TF interactions recorded in the atlas
represent new combinations not yet documented in the litera-
ture. Thus, an important question is how particular interactions
of interest should be carried forward in the laboratory to identify
new transcriptional heterodimers and to study their regulatory
functions. As an example use of the atlas to identify tissue-
restricted heterodimers, four interactions were selected for
which at least one TF had moderate to high tissue specificity
(Figure 4A). For example, Peroxisome Proliferator-Activated
Receptor Gamma (PPARG) is expressed in adipose, skin, lung,
and breast, with little or no expression in other tissues . Although
its interaction partner, Retinoid X Receptor Beta (RXRB), is ex-
pressed ubiquitously the interaction requires the presence of
both TFs and thus remains tissue restricted (Table S5).
Given these tissue-restricted TF combinations, a first step
was to characterize and further establish their physical interac-
tion. We used bidirectional in vitro pull-down assays to examine
whether each TF pair could exhibit strong, stable, and direct
physical binding under the conditions of the pull-down, inde-
pendent of other proteins or factors. As shown in Figure 4B,
all four TF interactions were recapitulated as in vitro pull-downs,
making them strong candidates for functional transcriptional
complexes.
Next, we sought detailed information on the dynamic expres-
sion of a TF combination in the tissue(s) in which both TFs were
active. One of the identified TF interactions was between Friend
Leukemia virus Integration 1 (FLI1) and SMAD family member
3 (SMAD3), in which FLI1 was restricted primarily to macro-
phage-related tissues (THP-1, spleen, lymph) while SMAD3
was found to be expressed more generally (Figure 4A and
Table S5). Thus, we investigated the role of the FLI1/SMAD3
interaction in macrophage differentiation, using qRT-PCR to
record a time-course of expression of both TFs during differen-
tiation of THP-1 monoblasts to monocytes following stimulation
by PMA. Strikingly, both TFs were coordinately downregulated
at early time points during differentiation (Figure 4C). These
data are supported by previous findings in which SMAD3 has
Figure 3. TF Subnetworks Conserved
across Human and Mouse
(A–F) Examples of TF subnetworks conserved in
specific tissues. Human proteins are circles and
mouse proteins are diamonds, colored in
increasing shades of red representing increasing
tissue specificity (TSPS), (Table S1). Stars indicate
hubs. Horizontal dashed links indicate protein or-
thology relationships across species, whereas
solid links indicate protein-protein interactions
within species (red links are newly-discovered,
black links are literature-curated).
(D–F) Conserved TF subnetworks that are specific
to cerebellum, as first indicated by qRT-PCR (red
nodes and Table S5) and subsequently confirmed
by in situ hybridization to mouse brain tissue
samples. All conserved subnetworks are available
at http://fantom.gsc.riken.jp/4/tf-ppi.been shown to regulate cell proliferation through TGF-b1
signaling (Meran et al., 2008), and FLI1 has been shown to re-
activate NOTCH pathways resulting in p53-dependent cell-cycle
arrest (Ban et al., 2008). A hypothesis for future work is that FLI1/
SMAD3 may function together as a repressor complex that
controls cell proliferation during differentiation (Figure 4D).
DISCUSSION
In this study, we have mapped an atlas of combinatorial interac-
tions among the majority of human and mouse TFs. This work
makes available a number of significant resources for the
biomedical community, including a database of over 1600
human or mouse TF-TF interactions (Tables S2 and S3) and
quantitative TF expression measurements across human and
mouse tissues (Table S5). The data highlight conserved TF
subnetworks whose patterns of interaction and tissue specificity
suggest transcriptional complexes in control of tissue identity.
Our analysis, derived by the integration of these datasets,
supports a model whereby the transcriptional network structure
is dominated by facilitator TFs expressed broadly across tissuesCell 140, 744–7(Figure 1 and Table S1). The implication is
that tissue identity is not determined by
tissue-restricted TFs, but relies on
tissue-restricted interaction among TFs.
Each TF may be expressed in a variety
of tissues, but it is only where two TFs
are coexpressed and colocalized that an
interaction, and its functional conse-
quences, may occur. In this model,
tissues restricted TFs (specifiers) tend to
interact with TFs that are broadly-ex-
pressed (Figure 1), increasing the number
of possible combinatorial events only in
certain tissues or during tightly-regulated
developmental processes. In support of
this interaction-centric model, we identi-
fied a subnetwork of just 15 TFs that
was sufficient to confer maximal separa-tion of tissues and stem cell lines into the three germ layers asso-
ciated with embryogenesis (Figure 2). This network significantly
outperformed tissue separation based on the expression of indi-
vidual factors alone. Two thirds of these ‘‘germ layer’’ factors
were facilitator TFs expressed in the majority of tissues.
The theme of specificity through interaction is also evident
among the conserved TF subnetworks (Figure 3). The majority
of TFs in these networks are broadly expressed, and it is the
minority of TFs that confer tissue specificity. Further evidence
comes from the four identified TF complexes we validated and
placed into biological contexts (Figure 4 and Table S5). Although
they were not selected on this basis, at least three of these
complexes involve combination of a tissue restricted TF (i.e.,
NR3C1, PPARG, FLI1) with a partner whose expression pattern
is more widespread (RXRB, RXRB, SMAD3).
The availability of large TF-TF combinatorial interaction
networks in both human and mouse will provide many opportu-
nities to study network conservation and divergence over the
course ofmammalian evolution. Debate is still ongoing regarding
the rate at which various types of molecular networks evolve.
Here, we found that conservation between human and mouse52, March 5, 2010 ª2010 Elsevier Inc. 749
Figure 4. Physical and Functional Explora-
tion of Tissue-Restricted Heterodimers
(A) Four heterodimers that display combinatorial
logic across tissues. The heatmap shows the
mRNA copy number of each heterodimeric TF
across tissues measured by qRT-PCR (Table S5).
(B) In vitro pull down experiment shows clear bidi-
rectional physical interaction for each of the four
heterodimers as detected originally by M2H assay
(Table S2).
(C) mRNA levels of FLI1 and SMAD3 during THP-1
differentiation induced by PMA, as measured by
qRT-PCR.
(D) Graphical representation of FLI1/SMAD3
control during myeloid differentiation.TF-TF interactions was moderate (Figure 3), in the range of 34 to
64 percent. In contrast, a recent comparison of transcriptional
(protein-DNA) interactions reported that this type of network is
highly divergent over even very short evolutionary timescales
(Tuch et al., 2008). A comparison of genetic networks (synthetic
lethal and epistatic interactions) also found extreme rates of
divergence (Roguev et al., 2008). On the other hand, protein-
protein interactions, especially those that form major structural
and functional components of the eukaryotic cell, were found
to be highly conserved (Tan et al., 2008a). Protein-protein inter-
actions forming transcriptional complexes, as we have studied
here, appear to be conserved at an intermediate level some-
where between the extremes. That is, TF-TF complexes are likely
more mutable than the major complexes of cell structure and
central metabolism, but much less so than the rapid rewiring
that appears to take place in networks of transcription factor /
promoter binding.
It has long been appreciated that gene regulation involves
combinatorial interactions among transcription factors. The
contribution of the present work is to map, on a global scale,750 Cell 140, 744–752, March 5, 2010 ª2010 Elsevier Inc.precisely what many of these connec-
tions are. With few exceptions, almost
all of the uncovered connections are
undocumented in the existing literature.
Future work will dissect more precisely
how each of these combinations contrib-
utes to developmental programs and to
an individual’s relative state of health or
disease.
EXPERIMENTAL PROCEDURES
Mammalian Two-Hybrid Assays
Following PCR amplification of full-length TFs,
M2H was carried out as previously described
(Usui et al., 2005). To assess potential for self-acti-
vation each BIND TF fragment (bait) was trans-
fected into CHO-K1 cells containing the luciferase
reporter plasmid pG5luc. Reporter activity was
measured after 20 hr and BIND samples with
high self-activation (more than 53 larger than
average) were removed. For non-self-activating
baits, eight BIND TF fragments (baits) and two
ACT TF fragments (preys) were cotransfectedinto CHO-K1 cells with pG5luc, and luciferase reporter activity was measured
after 20 hr. The screen was also performed using two BIND TFs combined with
two ACT TFs. For transfections with positive reporter activity, the assay was
repeated using all 23 2 or 83 2 BIND/ACT combinations to identify the inter-
acting TF pairs. Positive interactions were scored as those that showed at least
three times higher luciferase activity than background (measured using trans-
fection of either an ACT-TF or BIND-TF alone). For more details see Supple-
mental Information, Table S2, and Table S3.
In Vitro Pull-Down Assay
PCR products encoding the TF coding sequence and the SV40LPAS fragment
were used to construct a template for in vitro transcription/translation. The
products were combined by overlapping PCR using the primer pair T7-RBS-
KOZAK (50-GAGCGCGCGTAATACGACTCACTATAGGGGAAGGAGCCGCC
ACCATG-30) and LGT10L (50-AGCAAGTTCAGCCTGGTTAAG-30), yielding
a final template encoding a 50 T7 RNA polymerase promoter. In vitro pull-
down assays were carried out as previously described (Suzuki et al., 2004).
Briefly, biotinylated or [35S]-labeled TF was synthesized in vitro from the
template using Transcend Biotinylated lysine-tRNA (Promega) or Redivue
L-[35S]-methionine (Amersham Biosciences) in combination with the TNT T7
Quick Coupled Transcription/Translation System (Promega). After confirma-
tion of [35S]-labeled protein synthesis by SDS–PAGE and autoradiography, bi-
otinylated protein and [35S]-labeled protein were mixed 1:1 and incubated on
ice for one hour. Control reactions containing [35S]-labeled protein alone were
conducted in parallel. The reaction was then incubated with streptavidin Dyna-
beads (Dynal Biotech, Milwaukee, WI) for 30 min at 4C on a rotary shaker. Dy-
nabeads were isolated with a magnet and washed 5 times with ice-cold TBST
buffer (50 mM Tris-HCl [pH 8.0], 137 mMNaCl, 2.68 mMKCl, 0.1% Tween 20).
The amount of radio-labeled protein coprecipitated with the biotinylated
protein was measured by scintillation counting or was detected by SDS-
PAGE. The ratio of scintillations with and without biotinylated protein was
calculated to measure the interaction between the two proteins (Table S4).
Tissue Specificity Score
The value f ij , the fractional expression level of TF i in tissue j, was computed as
the ratio of the TF expression level in tissue j (qRT-PCR) to its sum total expres-
sion level across all tissues. Tissue specificity TSPSi was then computed using
relative entropy:
TSPSi =
X
j
f ij log2f
i
j =

qi

where qi is the fractional expression of TFi under a null model assuming
uniform expression across tissues. According to this definition, a minimal
TSPS = 0 would be reported for TFs expressed uniformly across all tissues,
while a maximal TSPSy 5 would be reported for TFs expressed only in a sin-
gle tissue. The threshold chosen for classifying TFs as tissue ‘‘specifiers’’
(TSPS R 1) was based on the observed bimodal distribution of expression
over all TFs and tissues (Figure 1A). This threshold is conservative, as it selects
TFs with roughly a 20-fold expression difference or greater across tissues
(Tables S1 and S5).
Unsupervised Tissue Separation
Two different feature sets were considered for tissue separation: (1) TF expres-
sion values and (2) TF-TF interaction values. For both feature sets the raw qRT-
PCR expression values were normalized so that each tissue had the same
average value over all TFs, then log transformed (Tables S1 and S5). Following
(Taylor et al., 2009) interaction values were computed for each interaction
between a hub and any other TF, with hubs taken as TFs with > 12 interactions
(Figure 1C, Table S2, and Table S3). Separations were performed using
a hybrid two-phase procedure. The first phase was noncentered Principal
Components Analysis (ncPCA), in which the second principal component re-
sulting from this analysis (PC2) was found to be the main direction informative
for tissue separation (either feature set). The features were then ranked ac-
cording to their absolute PC2 loadings and a second phase of dimensionality
reduction was performed using the ranked features. For this second phase,
noncentered Kernel PCA (ncKPCA) was used with two parameters: (1) the
standard deviation of the Gaussian kernel and (2) the number of top-ranked
features selected for separation. Performance of separation into the tissue
classes was measured by the Bezdek cluster validity index (CVI) considering
the first two dimensions (PC1, PC2). Further details are provided in the Supple-
mental Information.
We also examined the dependence of tissue specification on the particular
network used. Although the M2H network reported here (Tables S2 and S3) is
the first large-scale experimental screen for TF-TF interactions, previous
studies have sought to predict relevant TF combinations based on co-occur-
rence of TF binding sites within gene promoters (Yu et al., 2006). However, we
found that a network of TF pairs predicted using binding site co-occurrence
did not perform as well as the network of physical TF interactions elucidated
by M2H and previous literature (Figure 2A). We also found that the perfor-
mance of network-based tissue specification was not dependent on the
particular algorithm used for separation. Both ncKPCA and Sammon Mapping
approaches yielded very similar performance with Cluster Validity Index
(CVI) y 1, and in both cases CVI was maximized for exactly six interactions
(Figure 2F).
Data and Analysis Results
The data and analysis results of the paper are available from http://fantom.gsc.
riken.jp/4/tf-ppi.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, one
figure, and six tables and can be found with this article online at doi10.1016/
j.cell.2010.01.044.
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